UK firm seeks to market world's first malaria vaccine

(FILES) A mosquito is bloated with blood as it inserts its stinger into human flesh in this undated file photo obtained from the US Department of Agriculture. British drug maker GlaxoSmithKline (GSK) said on October 8, 2013 it hoped to get the green light for a prototype vaccine against malaria after trials showed it offered children a partial shield against the disease. Results for the Phase III stage of the closely-followed RTS,S vaccine were unveiled at a conference in Durban, South Africa, gathering experts on malaria in Africa.